Sandy Cove Advisors, LLC Revolution Medicines, Inc. Transaction History
Sandy Cove Advisors, LLC
- $275 Million
- Q2 2025
A detailed history of Sandy Cove Advisors, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Sandy Cove Advisors, LLC holds 27,008 shares of RVMD stock, worth $952,302. This represents 0.36% of its overall portfolio holdings.
Number of Shares
27,008
Previous 27,008
-0.0%
Holding current value
$952,302
Previous $955,000
3.98%
% of portfolio
0.36%
Previous 0.39%
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
312Shares Held
187MCall Options Held
186KPut Options Held
672K-
Vanguard Group Inc Valley Forge, PA15.8MShares$556 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.5MShares$477 Million2.75% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$473 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$416 Million0.08% of portfolio
-
Janus Henderson Group PLC London, X010.2MShares$359 Million0.21% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.09B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...